N-{[1-(2-phenylethyl)pyrrolidin-2-yl]methyl}cyclohexanecarboxamides as selective 5-HT(1A) receptor agonists

Bioorganic and Medicinal Chemistry Letters

Volumn 10, Issue 5, 2000, Pages 509-512

  Fujio, Masakazu ^a   Togo, Yoshifumi ^b   Tomozane, Hideo ^c   Kuroita, Takanobu ^c   Morio, Yasunori ^a   Katayama, Jiro ^a   Matsumoto, Yasuhiro ^c  

^a Exploratory Research I   (Japan)

^b Pharmaceutical Research Division   (Japan)

^c Drug Discovery Laboratories P   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; BENZAMIDE DERIVATIVE; HALOPERIDOL; KETANSERIN; N [[1 (2 PHENYLETHYL)PYRROLIDIN 2 YL]METHYL]CYCLOHEXANECARBOXAMIDE; SEROTONIN 1A AGONIST; SEROTONIN 1A RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHEMICAL MODIFICATION; CONCENTRATION (PARAMETERS); DORSAL RAPHE NUCLEUS; DRUG INHIBITION; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; IC 50; NERVE CELL; NONHUMAN; RECEPTOR AFFINITY;

AMIDES; ANIMALS; BINDING, COMPETITIVE; NEURONS; PYRROLIDINES; RAPHE NUCLEI; RATS; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, DOPAMINE D2; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN AGONISTS;

ANIMALIA;

EID: 0034611153     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(00)00030-5     Document Type: Article

References (18)

1. Fletcher A., Cliffe I.A., Dourish C.T. Trends Pharmacol. Sci. 14:1993;441.
2. Ahlenius S. Pharmacol. Toxicol. 64:1989;3.
3. Hicks P.B. Life Science. 47:1990;1609.
4. Glennon R.A., Dukat M. Serotonin. 2:1997;351.
5. O'Connor S.E., Brown R.A. Gen. Pharmacol. 13:1982;185.
6. Högberg T. Drugs Future. 16:1991;333.
7. Ikebe T., Murakami S., Takehara S., Sakamori M. Chem. Pharm. Bull. 39:1991;3370.
8. Kuroita T., Ikebe T., Murakami S., Takehara S., Kawakita T. Bioorg. Med. Chem. Lett. 5:1995;1245.
9. Cesario M., Pascard C., Moukhtari M.E., Jung L. Eur. J. Med. Chem. 16:1981;13.
10. van de Waterbeemed H., Testa B. Helv. Chim. Acta. 64:1981;2183.
11. van de Waterbeemed H., Carrupt P.A., Testa B. J. Mol. Graphics. 4:1986;51.
12. Collin S., Evrard G., Durant F. J. Cryst. Spectrosc, Res. 16:1986;255.
13. Humbert L.G., Bruderlein F.T., Philipp A.H., Gortz M. J. Med. Chem. 22:1979;761.
14. Anker L., Lauterwein J., van de Waterbeemed H., Testa B. Helv. Chim. Acta. 67:1984;706.
15. Collin S., Tayar N.El., van de Waterbeemed H., Moureau F., Vercautern D.P., Durant F., Langlois M., Testa B. Eur. J. Med. Chem. 24:1989;163.
16. Optical rotations were measured in methanol at 25 °C for compounds 7-(S) (-83.2°, c=1.0) and 7-(R) (+82.0°, c=1.0).
17. 3, 400 MHz) δ: 1.14-1.33 (5H, m), 1.41-1.47 (1H, m), 1.58-1.83 (9H, m), 2.20-2.25 (1H, m), 2.46-2.55 (2H, m), 2.70-2.97 (4H, m), 3.27-3.31 (1H, m), 3.44-3.50 (1H, m), 5.50 (1H, brs), 7.19-7.31 (5H, m).
18. Katayama J., Yakushiji T., Akaike N. Brain Res. 745:1997;283.